This Week in Virology

TWiV is a weekly netcast about viruses - the kind that make you sick. Brought to you by four university professors and a science writer.

http://www.microbe.tv/twiv

subscribe
share






episode 1086: Clinical update with Dr. Daniel Griffin


In his weekly clinical update, Dr. Griffin discusses the how the pandemic influenced the healthcare job market and why people conceal their infectious diseases before he reviews most recent statistics on the circulation of respiratory syncytial virus, influenza virus and SARS-CoV-2 virus, including all circulating variants in the US, discusses if susceptibility and disease severity are inheritable traits, if vaccination during pregnancy protects neonates or leads to adverse effects, the effectiveness of a monovalent XBB.1.5 against disease resulting from infection with Omicron variants, whether vaccination in the same or opposite arms effect antibody protection, continues to dispel the myth of viral rebound, how to pay for paxlovid, when to use steroids and the benefits of convalescent plasma, how SARS-CoV-2 infection may alter one’s sleep patterns, what the health and economic burdens of mild disease are, and if there are predictors for recovery from fatigue and cognitive deficits following SARS-CoV-2 infection.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode
  • Do you want a job in healthcare? (JAMA)
  • Why people don’t tell the truth about infectious diseases (Psychological Science)
  • Respiratory  disease surveillance (CDC)
  • RSV surveillance  (CDC)
  • RSV national trend (CDC)
  • Influenza/flu surveillance  (CDC)
  • Influenza/flu map (CDC)
  • COVID-19  hospital admissions (CDC)
  • COVID-19 national trend (CDC)
  • COVID-19 wastewater testing (biobot)
  • Variant tracker (CDC)
  • Variant hospital admissions (CDC)
  • Is susceptibility and severity of COVID-19 inheritabile (Nat Comm)
  • Neonates of vaccinated mothers (JAMA)
  • How is the monovalent XBB.1.5 vaccine effectiveness against symptomatic infection  Sept 2023-Jan 2024 (MMWR)
  • Second dose in the opposite arm improves antibody response (JCI)
  • Virus specific immune repsonses following contralateral or ipsilateral immunication (eBioMedicine)
  • CDC Quarantine guidelines (CDC)
  • To rebound or to not rebound (MMWR)
  • Know your COVID-19 tools (ESMED)
  • How to pay for Paxlovid (PAXCESS)
  • Molnupiravir safety and efficacy (JMV)
  • Convalescent plasma recommendation for immunocompromised (IDSociety)
  • Steroids,dexamethasone at the right time (OFID)
  • Anticoagulation guidelines (hematology.org)
  • How COVID-19 affected your sleep (Frontiers in Public Health)
  • Health and economic burden of COVID-19 after illness (BMC Medicine)
  • Predicting recovery from fatigue and cognitive deficits after COVID-19 (eClinical Medicine)
  • Contribute to our ASTMH fundraiser at PWB
  • Letters read on TWiV 1086
  • Dr. Griffin’s COVID treatment summary (pdf)
  • Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to daniel@microbe.tv


fyyd: Podcast Search Engine
share








 February 10, 2024  43m